SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

$RARI is an ERC-20 token that controls the RARI Foundation treasury and governs the Rarible protocol and RARI Chain. The token was issued in 2020 with a max. supply of 25 million $RARI.

Rarible

Rarible is currently trending due to community speculation around its ultra-low circulating supply and potential for high-percentage gains if volume increases. Traders are actively debating the token's long-term utility in the NFT sector while calling for broader exchange listings to catalyze a significant price move.

Sharplink, Inc. is an institutional-grade Ethereum treasury platform that provides public market investors with exposure to ETH. The platform focuses on Ethereum, which is used in various stablecoin, tokenized real-world asset, and decentralized finance settlement applications. This allows for native yield generation and potential network growth opportunities with ETH. The company is also involved in the online affiliate marketing business. The company was founded in 2019 and is headquartered in Miami, FL.

Sharplink Inc.

SharpLink Gaming Ltd

SharpLink Gaming is drawing attention as investors closely monitor its Ethereum treasury strategy and the significant discount to net asset value, fueling active community debate over the stock's long-term viability versus its recent downward price action. While some participants are capitalizing on the depressed levels as a contrarian opportunity, others remain skeptical about management's dilution practices and the overall performance of crypto-treasury holdings.

Maul Coin

Maul Coin is generating buzz among traders who are actively coordinating raids to drive engagement and increase holder count, positioning it as a community-driven alternative to volatile projects. Community members are rallying behind the active involvement of the developer while focusing on building long-term growth and visibility across social platforms.

Welcome to the fabulous world of OKANE, where wealth meets wagging tails!   Inspired by the Japanese word for "money," OKANE is more than just a meme coin; it’s a celebration of all things cute, quirky, and oh-so-luxurious.  Meet our charming mascot, a pampered pup with a flair for the extravagant. With his sparkling collar and stylish shades, this adorable canine knows how to live the high life. Whether he’s lounging in a sun-soaked doggy mansion or attending exclusive puppy parties, our little tycoon embodies the spirit of prosperity and joy.

OKANE

OKANE is attracting attention for its controlled price action and steady accumulation patterns, with community members emphasizing a patient, long-term outlook on its market movement.

TOSHI

TOSHI is trending as investors debate whether the current price action represents a major accumulation opportunity or a bottoming-out phase. Community sentiment remains polarized, with some members expressing frustration over stagnant price action and market volatility, while others remain committed to long-term holding and aggressive buying of the dip.

Bitcoin Cash is a hard fork of Bitcoin with a protocol upgrade to fix on-chain capacity. Bitcoin Cash intends to be a Bitcoin without Segregated Witness (SegWit) as soft fork, where upgrades of the protocol are done mainly through hard forks and without changing the original economic rules of the Bitcoin.  Bitcoin Cash (BCH) is released on 1st August 2017 as an upgraded version of the original Bitcoin Core software. The main upgrade is the increase in the block size limit from 1MB to 8MB. This effectively allows miners on the BCH chain to process up to 8 times more payments per second in comparison to Bitcoin. This makes for faster, cheaper transactions and a much smoother user experience.  Why was Bitcoin Cash Created?  The main objective of Bitcoin Cash is to to bring back the essential qualities of money inherent in the original Bitcoin software. Over the years, these qualities were filtered out of Bitcoin Core and progress was stifled by various people, organizations, and companies involved in Bitcoin protocol development. The result is that Bitcoin Core is currently unusable as money due to increasingly high fees per transactions and transfer times taking hours to complete. This is all because of the 1MB limitation of Bitcoin Core’s block size, causing it unable to accommodate to large number of transactions.  Essentially Bitcoin Cash is a community-activated upgrade (otherwise known as a hard fork) of Bitcoin that increased the block size to 8MB, solving the scaling issues that plague Bitcoin Core today.  Nov 16th 2018: A hashwar resulted in a split between Bitcoin SV and Bitcoin ABC

Bitcoin Cash

Bitcoin Cash is capturing community attention as investors debate its long-term viability, price potential, and its role as a peer-to-peer electronic cash alternative to Bitcoin. While some users express frustration over stagnant price action, others are focused on upcoming network upgrades and potential decoupling from broader crypto market volatility.

EyePoint Plc is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.

EyePoint Inc.

EyePoint Pharmaceuticals Inc

EyePoint Pharmaceuticals is currently trending as investors closely monitor the upcoming Phase 3 data for Duravyu, with the community actively debating the company's competitive positioning against Ocular Therapeutix. Discussion remains highly sensitive to institutional buying activity and the impact of broader market volatility on its clinical-stage valuation.

GraniteShares ETF Trust - GraniteShares 2x Long COIN Daily ETF

GraniteShares 2x Long COIN Daily ETF

CONL is seeing significant volatility and elevated trading volume as investors debate its role as a high-risk, 2x leveraged swing trade compared to traditional long-term holding. The community is actively discussing the stock's potential for an outsized recovery tied to Bitcoin price stabilization, upcoming regulatory developments, and potential Q1 earnings surprises.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is seeing increased market activity as traders react to positive signals regarding institutional adoption and its technical differentiation as a quantum-resistant layer-1 blockchain. The community remains divided between long-term holders focusing on ecosystem development and speculative traders debating its potential for a rebound following extended periods of price volatility.

Lam Research Corp. engages in the design, manufacture, marketing, refurbishment, and provision of semiconductor processing equipment used in the fabrication of integrated circuits. It operates through the following geographical segments: United States, China, Europe, Japan, Korea, Southeast Asia and Taiwan. The company was founded by David K. Lam in 1980 and is headquartered in Fremont, CA.

Lam Research Corp.

Lam Research is currently trending as investors weigh strong quarterly earnings and optimistic revenue guidance against ongoing geopolitical concerns regarding China-related export restrictions and potential tariff impacts. The community is actively debating the stock's long-term growth potential in the AI infrastructure space versus the risks posed by supply chain volatility and aggressive institutional positioning.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Pediatrix Medical Group, Inc. (NYSE:MD) Given Consensus Recommendation of "Hold" by Analysts

Shares of Pediatrix Medical Group, Inc. (NYSE:MD - Get Free Report) have received a consensus recommendation of "Hold" from the seven brokerages that are covering the company, MarketBeat Ratings...

Here's Why Pediatrix Medical Group (MD) is a Strong Momentum Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Pediatrix Medical Group (MD) is a Top-Ranked Growth Stock: Should You Buy?

Tudor Investment Corp ET AL Decreases Stake in Pediatrix Medical Group, Inc. $MD

Tudor Investment Corp ET AL lessened its holdings in shares of Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 48.9% during the third quarter, according to its most recent disclosure with...

JPMorgan Chase & Co. Increases Stake in Pediatrix Medical Group, Inc. $MD

JPMorgan Chase & Co. grew its stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 20.5% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 827,075 shares of the company's stock...

Pediatrix Ties Up to Provide Better Maternal Care in Tennessee

MD expands maternal care in Tennessee through a new partnership, boosts high-risk pregnancy services and aims for immediate earnings accretion.

Teladoc (TDOC) Up 3.2% Since Last Earnings Report: Can It Continue?

Teladoc (TDOC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Pediatrix Expands Maternal Health Services in Tennessee in Partnership with Tennessee Maternal-Fetal Medicine

Pediatrix Medical Group, Inc. (NYSE: MD), a leading provider of physician services, today announced its expansion in Middle Tennessee through a partnership with Tennessee Maternal-Fetal Medicine...

Pediatrix Welcomes Two Nationally Renowned Physician Leaders

Pediatrix Medical Group, Inc. (NYSE: MD), a leading provider of physician services, is pleased to announce that James Barry, M.D., MBA, will soon join the organization as Chief Clinical Quality...

Pediatrix Medical Group (NYSE:MD) Stock Price Crosses Above Two Hundred Day Moving Average - Time to Sell?

Pediatrix Medical Group (NYSE:MD) Stock Price Passes Above 200 Day Moving Average - Should You Sell...

Pediatrix Medical Group, Inc. engages in the provision of physician services. Its services include neonatal care, maternal fetal care, and other pediatric subspeciality care. The company was founded by Roger J. Medel in 1979 and is headquartered in Sunrise, FL.

Pediatrix Medical Group Inc

Opendoor ($OPEN)

Strategy ($MSTR)

American Eagle ($AEO)

Ondas Inc. ($ONDS)

The stock that proved the power of the crowd. Fueled by community energy and social momentum, this winner captivated retail investors regardless of what the "experts" or traditional fundamentals had to say.

Current Price	$21.18
Prev Close	$20.70
Open	$20.75
Dividend Yield	0.00%
50-Day Moving Average	$20.49
Beta	0.79
Avg. Volume	936,245.42
PE Ratio	10.93

52-Week High	$24.99
52-Week Low	$11.84
Market Capitalization	$1.76B
EPS (Annual)	$1.94
Price to Book	2.03
Revenue Per Employee	$291,079.70

MD
MEDNAX Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest MD News

MDMEDNAX Inc